These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10342749)

  • 1. Endogenous neutralizing anti-IL-1 alpha autoantibodies in inflammatory skin diseases: possible natural inhibitor for over expressed epidermal IL-1.
    Mizutani H; Ohmoto Y; Kupper TS; Shimizu M
    J Dermatol Sci; 1998 May; 20(1):63-71. PubMed ID: 10342749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of B cells in immune-mediated dermatoses.
    Wang WM; Guo L; Jin HZ
    Mol Immunol; 2020 Oct; 126():95-100. PubMed ID: 32795664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
    Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
    Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin-infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris.
    Schinner J; Cunha T; Mayer JU; Hörster S; Kind P; Didona D; Keber C; Hertl M; Worzfeld T; Juratli HA
    Front Immunol; 2023; 14():1203776. PubMed ID: 37415985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoimmune bullous skin diseases].
    Joly P
    Rev Med Interne; 1999 Jan; 20(1):26-38. PubMed ID: 10220817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human amnion membrane as a substrate for the detection of autoantibodies in pemphigus vulgaris and bullous pemphigoid.
    Sezin T; Avitan-Hersh E; Indelman M; Moscona R; Sabo E; Katz R; Pollack S; Bergman R
    Isr Med Assoc J; 2014 Apr; 16(4):217-23. PubMed ID: 24834757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-titer interferon-alpha antibodies in a patient with pemphigus foliaceus.
    Prümmer O; Zillikens D; Porzsolt F
    Exp Dermatol; 1996 Aug; 5(4):213-7. PubMed ID: 8889468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production.
    Bhol KC; Desai A; Kumari S; Colon JE; Ahmed AR
    Clin Immunol; 2001 Aug; 100(2):172-80. PubMed ID: 11465946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nonenzymatic glycosylation on the titers of circulating autoantibodies in pemphigus and pemphigoid.
    Nakagawa A; Kobayashi N; Yamashina Y; Nakatani C; Muramatsu T; Mori T; Shirai T
    J Dermatol; 1998 Nov; 25(11):710-5. PubMed ID: 9863283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
    Brooks WS; Lee YY; Abell E; Deng JS
    J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lichen planus pemphigoides with IgG autoantibodies to the 180 kd bullous pemphigoid antigen (type XVII collagen).
    Hsu S; Ghohestani RF; Uitto J
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):136-41. PubMed ID: 10607335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
    Bhol KC; Rojas AI; Khan IU; Ahmed AR
    Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
    Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
    J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An increased ratio of interleukin-1 receptor antagonist to interleukin-1alpha in inflammatory skin diseases.
    Terui T; Hirao T; Sato Y; Uesugi T; Honda M; Iguchi M; Matsumura N; Kudoh K; Aiba S; Tagami H
    Exp Dermatol; 1998 Dec; 7(6):327-34. PubMed ID: 9858135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels.
    Kapp A; Neuner P; Krutmann J; Luger TA; Schöpf E
    Acta Derm Venereol; 1991; 71(5):403-6. PubMed ID: 1684468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of anti-intercellular cement substance and anti-basement membrane zone antibodies by radioimmunoassay using SCaBER tumour cell line as substrate.
    Bevan HJ; Murahata RI; Ahmed AR
    Br J Dermatol; 1983 Sep; 109(3):261-5. PubMed ID: 6351893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay.
    Mouquet H; Drenovska K; Lartigue A; Joly P; Drouot L; Thomas M; Tron F; Gilbert D
    Clin Immunol; 2008 Nov; 129(2):304-12. PubMed ID: 18790674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes.
    Schmidt E; Reimer S; Kruse N; Jainta S; Bröcker EB; Marinkovich MP; Giudice GJ; Zillikens D
    J Invest Dermatol; 2000 Nov; 115(5):842-8. PubMed ID: 11069622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1 alpha specific inhibitor.
    Garrone P; Djossou O; Fossiez F; Reyes J; Ait-Yahia S; Maat C; Ho S; Hauser T; Dayer JM; Greffe J; Miossec P; Lebecque S; Rousset F; Banchereau J
    Mol Immunol; 1996; 33(7-8):649-58. PubMed ID: 8760277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.